Clinical Trials Logo

Clinical Trial Summary

Acute poisoning is a major public health problem all over the world, it causes significant mortality and morbidity. It primarily involves younger populations, with less than 3% of the affected cases being in people aged 60 years or older in most studies. More than half of the intoxication events in the elderly over 65 years old were accidental.


Clinical Trial Description

The elderly are different from younger adults in many aspects. There are age related physiological changes. They have a higher incidence of comorbidities and use of many medications for chronic conditions, both of which make the elderly more susceptible to acute poisoning and its related consequences. Although the elderly form a relatively small proportion of those admitted to hospital for acute self-poisoning, the poisoning in them is often more serious, complications are more frequent and a fatal outcome is more common. The presence of multiple physical, social, and psychiatric problems, with possible difficulties in the diagnosis of poisoning make the management of the elderly more complicated than that of younger poisoned patients. There are three main difficulties in diagnosing acute poisoning in the elderly. At first, it may not be easily obvious that the patient has taken an overdose. Secondly, the presence of pre-existing diseases may obscure the clinical picture and finally, the drug may cause physical signs that similar to common problems of old age. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05185570
Study type Observational
Source Sohag University
Contact Abeer H Mohammed
Phone 01019585267
Email abeer011116@med.sohag.edu.eg
Status Not yet recruiting
Phase
Start date January 2022
Completion date October 2022

See also
  Status Clinical Trial Phase
Completed NCT00780078 - Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure N/A
Not yet recruiting NCT05148611 - Application Registration Study of ILE in Patients With Acute Poisoning
Completed NCT06316362 - Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine Phase 2